Edge Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$180K Sell
2,104
-164
-7% -$13.7K 0.02% 330
2018
Q1
$181K Sell
2,268
-174
-7% -$14.4K 0.02% 326
2017
Q4
$197K Sell
2,442
-71
-3% -$5.69K 0.02% 309
2017
Q3
$195K Sell
2,513
-595
-19% -$49.4K 0.02% 306
2017
Q2
$275K Sell
3,108
-301
-9% -$25.4K 0.03% 278
2017
Q1
$274K Buy
3,409
+1,772
+108% +$138K 0.03% 284
2016
Q4
$116K Buy
+1,637
New +$129K 0.01% 359

Other funds holding MDT

Edge Advisors's MDT Position: Q2 2018 in Review

Edge Advisors reduced its Medtronic (MDT) stake by 7.2% in Q2 2018, selling an estimated $13.7K and leaving 2,104 shares worth $180K. The position accounts for 0.02% of the portfolio, ranked #330.

Edge Advisors first reported a position in MDT in Q4 2016 and has held it in 7 quarters since. The position peaked at $275K in Q2 2017. 1,409 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

  • Edge Advisors held 2,104 shares of Medtronic worth $180K as of Q2 2018.
  • Edge Advisors sold 164 Medtronic shares in Q2 2018, an estimated $13.7K.
  • Medtronic made up 0.02% of Edge Advisors's portfolio in Q2 2018, its #330 holding.
  • Edge Advisors first reported a position in Medtronic in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Medtronic position peaked at $275K in Q2 2017.
  • 1,409 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.